Bioavailability enhancement solutions from MerckIssue: June 20, 2013
| Category: Formulation, Bioavailability
Merck offers broad experience and deep application know-how in the field of bioavailabilit enhancement. As a full-service provider, we have everything you need to optimize development and reduce time to market. Our portfolio includes solubilizers and counterions such as meglumine (produced according to the ICH/Q7 guideline) to help enhance drug solubility, and a wide range of products to help optimize pharmacokinetic/pharmacodynamic profiles. They include our highly successful Parteck® products for controlled release, activated polyethylene glycols for PEGylation, and high-purity polyvinyl alcohol grades for use in hydrogels. Merck synthetic cationic and anionic lipids are designed to enhance drug targeting by entrapping APIs for extra protection; and with a vast portfolio of excipients besides those mentioned above, we can also help you produce formulations that boost the bioavailability of your final drug. Merck invests significantly in R&D to make substantial contributions to alleviate this industry bottleneck. For at-a-glance information on current key products and services, please see the first three pages in this issue of pharmail. For more details, just contact your sales partner – or click here. In This Same Issue: |
Recent Articles
Article Search
Article Archives
Events
Webinars
|